Tower Research Capital LLC (Trc) Artivion, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Artivion, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,738 shares of AORT stock, worth $105,673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,738
Previous 6,939
46.13%
Holding current value
$105,673
Previous $177,000
44.07%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding AORT
# of Institutions
175Shares Held
36MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$79.2 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$79 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$77.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$69.3 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.14B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...